PEG-MGF 2 mg – Pegylated Mechano Growth Factor (IGF-1Ec)

What is PEG-MGF (2 mg)?

PEG-MGF is a pegylated (PEG-modified) variant of mechano growth factor (MGF / IGF-1Ec) — a local splice variant of IGF-1 that is expressed in muscles in response to mechanical stress (stretching, overload) and injury. In the research literature, MGF is associated with the activation and proliferation of satellite (myogenic) cells — key to the early phase of muscle regeneration.

Pegylation (attachment of polyethylene glycol, PEG) has one main purpose: extending the half-life from minutes to hours/days, which increases stability and allows less frequent dosing in research protocols relative to unmodified MGF.

In the Peptology catalog, PEG-MGF is assigned to the category peptides for skin, sleep and libido, though functionally it belongs to the group of growth and regeneration compounds — alongside the "myostatin trap" ACE-031 or the regenerative copper peptide GHK-Cu.

It is a research compound — it is not a medicinal product and holds no authorization for clinical use. It must be emphasized that for PEG-MGF no widely available phase II/III clinical trials in humans have been published — most data come from preclinical and ex vivo models. The product offered by Peptology is a research-grade reagent.

In the version offered by Peptology, PEG-MGF is available in a 2 mg vial as a lyophilized peptide with purity ≥ 99%, confirmed by independent laboratory analysis (CoA for every batch). The product is intended exclusively for scientific research and in vitro applications.

Variant: PEG-MGF 2 mg

This page concerns one dosage variant — PEG-MGF 2 mg. Each vial contains 2 mg of the lyophilized peptide. A typical working reconstitution is 1 mL → 2 mg/mL (2000 µg/mL), and the research doses described in the literature usually fall in the range of 100–400 µg.

PEG-MGF is offered in the 2 mg variant. If you are researching the systemic action of IGF-1, check IGF-1 LR3, and for a regenerative repair partner — BPC-157.

How PEG-MGF works — the research mechanism

In the research literature, PEG-MGF is described as a tissue-specific isoform of the IGF-1 response, targeted at early muscle regeneration. Below are the three most frequently studied elements.

Why MGF differs from "ordinary" IGF-1

MGF (IGF-1Ec) is a splice variant of IGF-1 with local action — it appears in the muscle after overload and triggers an early regenerative response (satellite cells). This distinguishes it from the systemic IGF-1 LR3, which acts systemically and longer. It should be noted that for some MGF fragments, limited in vitro effects were also described — the mechanism is context-dependent.

In regenerative research, PEG-MGF is sometimes considered alongside compounds affecting muscles (like ACE-031) and reparative peptides (BPC-157). This data comes from studies and does not constitute a claim about the effect of the research-grade product offered by Peptology.

Pharmacokinetics and pharmacodynamics (research framework)

PEG-MGF is a pegylated IGF-1Ec isoform with extended stability. The most important research characteristics:

• Structure: mechano growth factor (IGF-1Ec) with attached PEG
• Targets: satellite cells / myoblasts, local IGF signaling (context-dependent)
• Half-life: extended by pegylation — from minutes (MGF) to hours/days (PEG-MGF)
• Reference concentration: 2 mg in 1 mL = 2 mg/mL (2000 µg/mL); research doses usually 100–400 µg
• Status of human data: no widely published phase II/III RCTs
• Route of administration in protocols: most often subcutaneous, per the research protocol

Comparison: PEG-MGF vs ACE-031 vs GHK-Cu

Within the same category, it is worth comparing PEG-MGF with two other growth and regeneration compounds — the "myostatin trap" ACE-031 and the regenerative GHK-Cu. Each addresses a different aspect of growth/regeneration.

PEG-MGF focuses on early muscle regeneration (satellite cells), ACE-031 on mass growth (myostatin blockade), and GHK-Cu on skin and collagen. The comparison is indicative in nature and does not constitute a recommendation for use.

Areas of research on PEG-MGF

PEG-MGF is an active area of research on muscle regeneration, with a strong caveat about the absence of large human studies. Below are the most frequently explored directions.

Muscle regeneration and satellite cells

The main direction of research on MGF/PEG-MGF concerns the activation and proliferation of satellite cells and the early phase of muscle rebuilding after overload or injury — mainly in preclinical and ex vivo models.

Stability through pegylation

Unmodified MGF has a very short half-life (minutes). The PEG variant was designed for longer stability and less frequent dosing — this is the main reason why PEG-MGF is preferred in research protocols on regeneration.

No phase II/III human data

It must be clearly noted: for PEG-MGF no widely available, randomized phase II/III clinical trials have been published. The mechanism can be context-dependent, and some in vitro observations are limited. This is an active research area, not a confirmed application.

Note: The information is presented for scientific and informational purposes and is based mainly on the preclinical and ex vivo literature. It does not constitute medical advice, a recommendation for use or a claim about the effect of the research-grade product offered by Peptology.

PEG-MGF profile at a glance

• Pegylated IGF-1Ec isoform (MGF) — a local muscle regeneration factor
• Satellite cell activation — the early phase of muscle rebuilding (models)
• Pegylation = stability — half-life from minutes to hours/days, less frequent dosing
• Local vs systemic: MGF acts locally, IGF-1 LR3 — systemically
• No widely published phase II/III RCTs in humans — data mainly preclinical
• Every batch with a CoA and purity ≥ 99%

All information provided refers to the research literature on MGF/PEG-MGF and should not be interpreted as a promise of effect, an instruction for use or a claim about the effect of the research-grade product offered by Peptology.

Research dosing protocols

In research protocols, PEG-MGF is usually administered after reconstitution of the lyophilizate, most often subcutaneously:

• Working reconstitution: 1 mL → 2 mg/mL (2000 µg/mL); the described research doses are usually 100–400 µg
• Thanks to pegylation, dosing is less frequent than with unmodified MGF (longer half-life)
• In regenerative research it is sometimes considered in a peri-training / post-overload context
• Calculate precise volumes and units in the peptide calculator (max. 3 mL per vial)

In combined protocols, PEG-MGF is sometimes considered alongside IGF-1 LR3, growth hormone secretagogues or regenerative complexes (like BPC-157). These schedules come from the research literature and do not constitute a recommendation for self-administration.

Side effects and safety

In research observations, PEG-MGF is described as well tolerated. Side effects are usually mild and transient. The data concern research on the molecule and are limited in humans.

Most reported effects are mild and transient; rare PEG-related reactions are possible. This information is scientific in nature and does not constitute an instruction for use.

Storage and reconstitution

PEG-MGF is supplied as a lyophilized (freeze-dried) powder in a vial. In lyophilized form it is stable at room temperature, protected from light and moisture — refrigeration before reconstitution is not mandatory. After reconstitution, stability depends on the solvent used, with Peptide Matrix Water™ significantly extending the peptide's lifespan.

• Before reconstitution: room temperature, in the original packaging, protected from light and moisture. A refrigerator is not mandatory.
• After reconstitution with Peptide Matrix Water™: stability in the refrigerator +2 °C to +8 °C for up to 60 days under appropriate laboratory conditions — the stabilizing formula extends the peptide's lifespan relative to standard solvents.
• After reconstitution with bacteriostatic or sterile water: stability in the refrigerator +2 °C to +8 °C for up to 28 days under appropriate conditions. Do not refreeze the reconstituted solution.
• Reconstitution: in a laboratory setting, Peptide Matrix Water™, bacteriostatic water or sterile water for injection is usually used, depending on the protocol.
• Volume: maximum 3 mL of solvent (capacity of a standard vial). For a precise calculation of volume and units, use the peptide calculator.
• Homogenization: add the solvent slowly down the vial wall, without vigorous shaking, then wait 10–15 min. Swirl gently, do not shake.

Laboratory tip: With your order, you can add Peptide Matrix Water™ to the cart — a stabilizing solution designed for working with reconstituted research peptides. More in the article Bacteriostatic water vs acetic acid vs matrix water.

Frequently asked questions about PEG-MGF

What exactly is PEG-MGF?

It is a pegylated variant of mechano growth factor (MGF / IGF-1Ec) — a local variant of IGF-1 induced by mechanical stress in muscles. It is studied for the activation of satellite cells and early regeneration. The results come mainly from preclinical models.

What is the difference between MGF and PEG-MGF?

Unmodified MGF has a very short half-life (minutes). The PEG variant (with attached polyethylene glycol) was designed for longer stability (hours/days) and less frequent dosing.

Does PEG-MGF act via the IGF-1 receptor?

The data suggest the involvement of IGF-related pathways and satellite cells, but the mechanism is context-dependent — there are also publications describing limited in vitro effects for some MGF fragments.

Are there published RCTs in humans?

Currently, no widely available phase II/III studies on PEG-MGF have been published. Most data come from preclinical and ex vivo sources — this is an early, active area of research.

How is PEG-MGF stored and reconstituted?

The lyophilized vial is stored at room temperature, protected from light and moisture. After reconstitution, stability depends on the solvent: with Peptide Matrix Water™ — up to 60 days in the refrigerator +2 °C to +8 °C; with bacteriostatic or sterile water — up to 28 days. Avoid refreezing.

Where to buy PEG-MGF for research?

Peptology offers PEG-MGF (2 mg) as a research peptide with confirmed purity ≥ 99% and independent laboratory analysis for every batch. Fast shipping, discreet packaging and certificates of purity with the product. For scientific background, also see the article Peptides — what they are, how they work, main categories and safety profile.

Related products in the Peptology catalog

Researchers working with PEG-MGF often also consider related growth and regeneration compounds. Each of the products below has a certificate of purity (CoA):

See the full catalog: Peptides for skin, sleep and libido · Recovery and anabolic peptides · Peptides for energy and regeneration · All peptides · Blog on peptide research

Laboratory reconstitution

Laboratory protocol — reconstitution, research protocols, storage

Standardized protocol applicable to all research peptides in the Peptology catalogue. To calculate the solution concentration (mg/mL) for each vial, use the peptide reconstitution calculator.

60-second protocol

Quick reference

What you need

Five rules for reconstitution

Calculating concentration

Storage

Four mistakes to avoid

Shipping information

🚚 Shipping information

• Products in our warehouse – orders placed by 15:00 on working days are dispatched the same day, later orders on the next working day.

• Delivery with GLS to your address in 3–5 working days.

• Shipping costs €5 and is free from €50.

Frequently Asked Questions (FAQ)

What is the difference between MGF and PEG-MGF?

The unmodified MGF has a very short half-life (minutes); the PEG variant was developed for extended stability.

Does PEG-MGF act through the IGF-1 receptor?

Data indicate involvement of IGF-related pathways and satellite cells, but the mechanism is context-dependent; there are publications reporting limited in vitro effects for certain fragments.

Are there published randomized Phase II/III trials in humans?

To date there are no widely published Phase II/III trials for PEG-MGF; most data are preclinical/ex vivo.

Where can I buy PEG-MGF in Europe and what does it cost?

You can buy PEG-MGF in Europe online from Peptology, from 40,00 €. Delivery with GLS in 3–5 working days. Shipping is free from 50,00 €. Payment by card. Purity 99%+, with an HPLC report for every batch.

Laboratory Analysis

PEG-MGF - 2mg - Batch - 0226 - Purity